A Study of Aripiprazole in Patients With Major Depressive Disorder

NCT00105196 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Aripiprazole+ ADT
DRUG: Placebo+ ADT

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]